Physicians should be alert while treating patients with SLE who develop a new apparent rheumatic presentation with a decreased SLE-specific autoantibody titer, positive anti-RNP antibodies, and elevated CPK. This evidence concerns the gene RNPC3 and systemic lupus erythematosus.